Sunday, February 27, 2011

Quality Tickler File

The AP reported:
U.S. Department of Health and Human Services' inspector general reported that between 40 and 65 percent of clinical studies of federally regulated medical products were done in other countries in 2008, and that proportion probably has grown. The report also noted that U.S. regulators inspected fewer than 1 percent of foreign clinical trial sites.
Trust, but don't verify.  How might this express in the next decade?

No comments: